SIRT1 作为肺部疾病炎症老化的治疗靶点。

SIRT1 as a therapeutic target in inflammaging of the pulmonary disease.

机构信息

Department of Environmental Medicine, Lung Biology and Disease Program, University of Rochester Medical Center, Rochester, NY 14642, USA.

出版信息

Prev Med. 2012 May;54 Suppl(Suppl):S20-8. doi: 10.1016/j.ypmed.2011.11.014. Epub 2011 Dec 8.

Abstract

OBJECTIVE

Chronic inflammation and cellular senescence are intertwined in the pathogenesis of premature aging, which is considered as an important contributing factor in driving chronic obstructive pulmonary disease (COPD). Sirtuin1 (SIRT1), a nicotinamide adenine dinucleotide (NAD(+))-dependent protein/histone deacetylase, regulates inflammation, senescence/aging, stress resistance, and deoxyribonucleic acid (DNA) damage repair via deacetylating intracellular signaling molecules and chromatin histones. The present review describes the mechanism and regulation of SIRT1 by environmental agents/oxidants/reactive aldehydes and pro-inflammatory stimuli in lung inflammation and aging. The role of dietary polyphenols in regulation of SIRT1 in inflammaging is also discussed.

METHODS

Analysis of current research findings on the mechanism of inflammation and senescence/aging (i.e., inflammaging) and their regulation by SIRT1 in premature aging of the lung.

RESULTS

COPD is a disease of the lung inflammaging, which is associated with the DNA damage response, transcription activation and chromatin modifications. SIRT1 regulates inflammaging via regulating forkhead box class O 3, p53, nuclear factor kappa B, histones and various proteins involved in DNA damage and repair. Polyphenols and its analogs have been shown to activate SIRT1 although they have anti-inflammatory and antioxidant properties.

CONCLUSIONS

Targeting lung inflammation and cellular senescence as well as premature lung aging using pharmacological SIRT1 activators or polyphenols would be a promising therapeutic intervention for COPD/emphysema.

摘要

目的

慢性炎症和细胞衰老在早衰的发病机制中相互交织,被认为是导致慢性阻塞性肺疾病(COPD)的重要因素。Sirtuin1(SIRT1)是一种烟酰胺腺嘌呤二核苷酸(NAD(+))依赖性蛋白/组蛋白去乙酰化酶,通过去乙酰化细胞内信号分子和染色质组蛋白来调节炎症、衰老/老化、应激抵抗和脱氧核糖核酸(DNA)损伤修复。本综述描述了 SIRT1 通过环境剂/氧化剂/反应性醛和促炎刺激在肺炎症和衰老中的作用机制和调节。还讨论了膳食多酚在调节炎症老化中的 SIRT1 作用。

方法

分析目前关于炎症和衰老/老化(即炎症老化)的机制以及 SIRT1 在肺过早老化中的调节作用的研究结果。

结果

COPD 是一种肺炎症老化疾病,与 DNA 损伤反应、转录激活和染色质修饰有关。SIRT1 通过调节叉头框 O3、p53、核因子 kappa B、组蛋白和参与 DNA 损伤和修复的各种蛋白来调节炎症老化。多酚及其类似物已被证明可激活 SIRT1,尽管它们具有抗炎和抗氧化特性。

结论

使用药理学 SIRT1 激活剂或多酚靶向肺炎症和细胞衰老以及肺过早老化,可能是治疗 COPD/肺气肿的一种有前途的治疗干预措施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索